• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Significant one-time order for Nexstim

Analyst Comment 12.06.2026, 08.28 by Antti Siltanen
Nexstim

Aiforia expands to nine hospitals in Spain

Analyst Comment 12.06.2026, 08.26 by Antti Siltanen
Aiforia Technologies

Nightingale: We factored the project delay into our estimates

Research 12.06.2026, 09.20 by Antti Siltanen, Antti Luiro
Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Nightingale's profit warning: Project delay shifts revenue to next year

Analyst Comment 09.06.2026, 08.40 by Antti Siltanen
Nightingale Health

Nexstim received a new sales authorization for the NBS 6 system in Australia

Analyst Comment 04.06.2026, 07.48 by Antti Siltanen
Nexstim

Nightingale: Nightingale sings to a deaf market

Research 04.06.2026, 08.36 by Antti Siltanen
Nightingale Health

Herantis: Clarity on efficacy study details

Research 03.06.2026, 10.21 by Antti Siltanen
Herantis Pharma

Bioretec seeks additional savings through change negotiations

Analyst Comment 02.06.2026, 09.18 by Antti Siltanen
Bioretec

Orion: Første resultater fra lægemiddelkandidat ODM-212

Analyst Comment 01.06.2026, 07.34 by Antti Siltanen
Orion

Nightingale joins wellbeing services county research project

Analyst Comment 29.05.2026, 08.46 by Antti Siltanen
Nightingale Health